Daniel A Rothenberg, PhD (@aspalaargphd) 's Twitter Profile
Daniel A Rothenberg, PhD

@aspalaargphd

Proteomics/Immunopeptidomics for @BioNTech_Group. Alum of @MITdeptofBE and @UTBiomedical. Tweets are my own opinions. Random sports ranting at @drothenberg0121

ID: 1536232099207782400

calendar_today13-06-2022 06:21:41

45 Tweet

123 Followers

200 Following

Martin Borch Jensen (@martinbjensen) 's Twitter Profile Photo

If you want to build a career in biotech, should you get a PhD after college or join a company directly (as a Research Associate/RA, usually)? There's no single answer, but I have the conversation often enough that I thought I'd share some pros/cons... (1/n)

If you want to build a career in biotech, should you get a PhD after college or join a company directly (as a Research Associate/RA, usually)? 
There's no single answer, but I have the conversation often enough that I thought I'd share some pros/cons... (1/n)
Daniel A Rothenberg, PhD (@aspalaargphd) 's Twitter Profile Photo

Click chemistry and bioorthogonal labeling approaches pioneered by Carolyn Bertozzi were key technologies that enabled my PhD thesis. It’s awesome to see it get recognized with the The Nobel Prize today

Daniel A Rothenberg, PhD (@aspalaargphd) 's Twitter Profile Photo

I'm hiring!! If you are curious, motivated, and interested in using the latest proteomics technology to answer questions at the frontier of immunology, immuno-oncology, and infectious diseases, check this out! jobs.biontech.de/Associate-Scie…

BioNTech SE (@biontech_group) 's Twitter Profile Photo

We and Pfizer Inc. started a Phase 1 trial for #BNT162b4 aimed at enhancing the breadth of t cell responses. This is part of our next generation #COVID19 vaccine candidate approach. Goal: potentially broaden and extend the duration of protection against COVID-19.

We and <a href="/pfizer/">Pfizer Inc.</a> started a Phase 1 trial for #BNT162b4 aimed at enhancing the breadth of t cell responses. This is part of our next generation #COVID19 vaccine candidate approach. Goal: potentially broaden and extend the duration of protection against COVID-19.
Eric Topol (@erictopol) 's Twitter Profile Photo

A T-cell directed vaccine against Covid, with non-spike, conserved antigens (e.g. nucleocapsid, ORF1ab), effective in experimental models for preventing disease, has gone into clinical trials clinicaltrials.gov/ct2/show/NCT05… cell.com/cell/fulltext/… Cell

A T-cell directed vaccine against Covid, with non-spike, conserved antigens (e.g. nucleocapsid, ORF1ab), effective in experimental models for preventing disease, has gone into clinical trials clinicaltrials.gov/ct2/show/NCT05…
cell.com/cell/fulltext/… <a href="/CellCellPress/">Cell</a>
Charlie Dulberger (@chaaawie) 's Twitter Profile Photo

Happy to share some of the innovative work at BioNTech SE. It's been amazing to have an insider perspective on the development of T cell-directed vaccine tech -- always thinking about ways to manipulate the T cell synapse to modulate immunity! cell.com/cell/fulltext/…

Daniel A Rothenberg, PhD (@aspalaargphd) 's Twitter Profile Photo

I’m so excited to share our journey developing a T-cell-directed mRNA vaccine for SARS-CoV-2 that can complement existing Spike-based vaccines. I’m incredibly grateful to be able to work with such a talented team to advance this technology to the clinic.

BioNTech SE (@biontech_group) 's Twitter Profile Photo

We are pleased to announce our strategic partnership with CEPI to advance the development of our #mRNA based BNT166 #vaccine program for the prevention of mpox. investors.biontech.de/news-releases/…

Daniel A Rothenberg, PhD (@aspalaargphd) 's Twitter Profile Photo

Does anyone know how to easily transfer the accounts I follow on here onto Bluesky/Mastadon/Threads/etc? I'm getting off this hellscape of a site but don't want to lose out on all the good science discussions